Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

August 14, 2014

Primary Completion Date

October 25, 2017

Study Completion Date

November 22, 2017

Conditions
Head and Neck NeoplasmsMucositis
Interventions
DRUG

Brilacidin

Oral Rinse used 3 times daily for 7 weeks

OTHER

Placebo

Trial Locations (16)

11794

Poughkeepsie

Stony Brook

14225

Cheektowaga

14642

Rochester

19140

Philadelphia

29425

Charleston

31904

Columbus

33805

Lakeland

40207

Louisville

43623

Toledo

44106

Cleveland

53211

Milwaukee

63110

St Louis

71103

Shreveport

85234

Gilbert

87131

Albuquerque

All Listed Sponsors
lead

Innovation Pharmaceuticals, Inc.

INDUSTRY